Thomas and Peter discuss the potential benefits and risks of inhibiting the synthesis of Apollo A, questioning its physiological function and its impact on human life. They explore the possibility of reducing Apollo A levels without eliminating it completely, highlighting the importance of safety in the development of the drug.
